Table 5.
Adverse effects, N (%) | Treatment group | p value | |
---|---|---|---|
ALC group (N = 34) | Placebo group (N = 35) | ||
Nausea | 7 (20.6%) | 3 (8.6%) | 0.19 |
Dyspepsia | 5 (14.7%) | 2(5.7%) | 0.26 |
Headache | 4 (11.8%) | 2 (5.7%) | 0.43 |
Diarrhea | 2 (5.9%) | 0 (0.0%) | 0.24 |
Note: ALC = acetyl-L-carnitine.